Portfolio item number 1
Short description of portfolio item number 1
Short description of portfolio item number 1
Short description of portfolio item number 2
Disease Control Priorities 4, forthcoming
This paper evaluates the social value of investing in vaccine research, development, and manufacturing capacity for pandemic preparedness and response. Rapid vaccination during pandemics can significantly reduce mortality, economic losses, and societal disruptions. However, vaccine manufacturers often lack sufficient incentives for speed and capacity expansion. Strategic policies by governments and international organizations could enhance these incentives and improve equitable vaccine distribution.
2024
This paper analyzes diversity of appointments to corporate boards using panel data for S&P 1500 firms from 2000Q1 to 2019Q4. Using a logistic model with two-way fixed effects and a bias correction, we evaluate the extent to which a board’s composition and the demographic characteristics of outgoing directors are associated with the appointment of diverse directors in terms of gender, race, and ethnicity.
Review of Economic Design, 2024
This paper quantifies the social value of a universal COVID-19 vaccine over the existing COVID-19 booster vaccines using Monte Carlo Simulations. It proposes the use of an advanced market commitment to incentivize its development.
2024
This paper evaluates the impact of increased access to Long-Acting Reversible Contraceptives (LARCs) on high school graduation rates through studying the 2009 Colorado Family Planning Initiative (CFPI).
Published:
This is a description of a teaching experience. You can use markdown like any other post.
Published:
This is a description of a teaching experience. You can use markdown like any other post.